Syndax Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Syndax Pharmaceuticals

03/08/2023 22:03

* Syndax Pharmaceuticals Inc  SNDX.OQ  reported a quarterly
adjusted loss of 64 cents​​ per share for the quarter ended in
June. The mean expectation of nine analysts for the quarter was
for a loss of 73 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Syndax Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 64 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Syndax Pharmaceuticals Inc shares had fallen by 2.2% this
quarter and lost 19.5% so far this year.
    * The company reported a quarterly loss of $44.62 million.
    * Wall Street's median 12-month price target for Syndax
Pharmaceuticals Inc is $36.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 09:03 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.73          -0.64          Beat
 Mar. 31 2023      -0.60          -0.59          Beat
 Dec. 31 2022      -0.65          -0.62          Beat
 Sep. 30 2022      -0.63          -0.58          Beat